Technical Analysis for ESPR - Esperion Therapeutics, Inc.

Grade Last Price % Change Price Change
F 9.14 -1.72% -0.16
ESPR closed down 1.72 percent on Friday, October 15, 2021, on approximately normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Nov 2
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical ESPR trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -1.72%
Volume Surge Other -1.72%
New 52 Week Low Weakness -1.72%
Multiple of Ten Bearish Other -1.72%
Wide Bands Range Expansion -1.72%
Gapped Down Weakness -1.72%
Older End-of-Day Signals for ESPR ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Esperion Therapeutics, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of therapies for the treatment of patients with low-density lipoprotein cholesterol and other cardiometabolic risk factors. Its products include ETC-1002, an oral molecule therapy that is in Phase IIa clinical trials to treat lipid and carbohydrate metabolic pathways; ESP41091, which is in pre-clinical trials for type 2 diabetes and obesity treatment; and 4WF, a synthetic therapy that is in pre-clinical trials to reverse the deleterious effects of atherosclerosis. The company is based in Plymouth, Michigan.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Diabetes Lipid Cardiology Obesity Cholesterol Lipoprotein Lipids Gabaa Receptor Positive Allosteric Modulators Low Density Lipoprotein Niacin Atherosclerosis Lipoproteins

Is ESPR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 39.495
52 Week Low 9.1001
Average Volume 764,825
200-Day Moving Average 21.94
50-Day Moving Average 12.32
20-Day Moving Average 11.22
10-Day Moving Average 10.21
Average True Range 0.68
ADX 30.21
+DI 12.20
-DI 32.88
Chandelier Exit (Long, 3 ATRs) 11.11
Chandelier Exit (Short, 3 ATRs) 11.13
Upper Bollinger Bands 13.51
Lower Bollinger Band 8.93
Percent B (%b) 0.05
BandWidth 40.86
MACD Line -0.86
MACD Signal Line -0.72
MACD Histogram -0.1402
Fundamentals Value
Market Cap 254.79 Million
Num Shares 27.9 Million
EPS -2.86
Price-to-Earnings (P/E) Ratio -3.19
Price-to-Sales 3.59
Price-to-Book 88.48
PEG Ratio -4.78
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.72
Resistance 3 (R3) 9.78 9.63 9.63
Resistance 2 (R2) 9.63 9.48 9.61 9.59
Resistance 1 (R1) 9.39 9.39 9.32 9.33 9.56
Pivot Point 9.24 9.24 9.21 9.22 9.24
Support 1 (S1) 9.00 9.09 8.93 8.95 8.72
Support 2 (S2) 8.85 9.00 8.83 8.69
Support 3 (S3) 8.61 8.85 8.65
Support 4 (S4) 8.56